Reteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Raja, Sandesh [1 ,4 ]
Ali, Azzam [1 ]
Qammar, Asfia [2 ]
Raja, Adarsh [3 ]
机构：
[1] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan
[2] Baylor Scott & White Heart & Vasc Hosp Dallas, Dallas, TX USA
[3] Shaheed Mohtarma Benazir Bhutto Med Coll Lyari, Karachi, Pakistan
[4] Dow Univ Hlth Sci, Dow Med Coll, BabaE Urdu Rd, Karachi 74200, Pakistan
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2025年 / 32卷 / 01期
关键词：
D O I：
10.1097/MJT.0000000000001823
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：e111 / e114
页数：4
相关论文
共 50 条
  • [31] Tirofiban for acute ischemic stroke: systematic review and meta-analysis
    Jinhong Gong
    Jingjing Shang
    Hai Yu
    Qian Wan
    Dan Su
    Zhiqiang Sun
    Guangjun Liu
    European Journal of Clinical Pharmacology, 2020, 76 : 475 - 481
  • [32] Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
    Zhang, Xu
    Wan, Teng-Fei
    Chen, Jing
    Liu, Liang
    AGING-US, 2023, 15 (24):
  • [33] Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
    Huang, Jian
    Zheng, Hui
    Zhu, Xianfeng
    Zhang, Kai
    Ping, Xiaofeng
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [34] Dual Antiplatelet Therapy versus Alteplase in Adult Patients With Minor Ischemic Stroke: A Systematic-Review and Meta-Analysis
    Viana, Patricia
    Relvas, Jessica Hoffmann
    Cabral, Thamiris Dias Delfino
    de Almeida, Artur Menegaz
    Persson, Jorge Eduardo Zanchi
    Persson, Marina Zanchi
    Marques, Marcos Vinicius Oliveira
    STROKE, 2024, 55
  • [35] The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials
    Mohamed Abuelazm
    Amith Reddy Seri
    Ahmed K. Awad
    Unaiza Ahmad
    Abdelrahman Mahmoud
    Ebraheem Albazee
    Soumya Kambalapalli
    Basel Abdelazeem
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 322 - 338
  • [36] The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials
    Abuelazm, Mohamed
    Seri, Amith Reddy
    Awad, Ahmed. K. K.
    Ahmad, Unaiza
    Mahmoud, Abdelrahman
    Albazee, Ebraheem
    Kambalapalli, Soumya
    Abdelazeem, Basel
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (02) : 322 - 338
  • [37] Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials
    Palaiodimou, Lina
    Katsanos, Aristeidis H.
    Turc, Guillaume
    Asimakopoulos, Alexandros-Georgios
    Mavridis, Dimitrios
    Schellinger, Peter D.
    Theodorou, Aikaterini
    Lemmens, Robin
    Sacco, Simona
    Safouris, Apostolos
    Katan, Mira
    Sarraj, Amrou
    Fischer, Urs
    Tsivgoulis, Georgios
    NEUROLOGY, 2024, 103 (09)
  • [38] Dual Antiplatelet Therapy vs Alteplase in Adult Patients with Acute Minor Ischemic Stroke: A Systematic Review and Meta-Analysis
    Viana, Patricia
    Relvas, Jessica Hoffmann
    Cabral, Thamiris Dias Delfino
    Persson, Jorge Eduardo
    de Almeida, Artur Menegaz
    Persson, Marina
    Marques, Marcos Vinicius Oliveira
    Oliveira-Filho, Jamary
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (06) : 929 - 935
  • [39] Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials
    Salamatullah, Hassan K.
    Bashrahil, Bader
    Alghamdi, Abdulaziz M.
    Alsharm, Faisal S.
    Alkulli, Osama A.
    Alzahrani, Ziyad
    Alkhiri, Ahmed
    Alghamdi, Saeed
    Makkawi, Seraj
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [40] Safety of edaravone in acute ischemic stroke: A systematic review and meta-analysis
    Badillo, Stephanie Patricia J.
    Navarro, Jose C.
    NEUROLOGY ASIA, 2023, 28 (01) : 39 - 53
12345